Related Experiment Video

Updated: Jun 16, 2026

Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses
06:13

Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses

Published on: November 24, 2014

Rac1 is required for oncolytic NDV replication in human cancer cells and establishes a link between tumorigenesis and

J Puhlmann1, F Puehler, D Mumberg

  • 1Bayer Schering Pharma AG, Global Drug Discovery, Berlin, Germany.

Oncogene
|January 27, 2010
PubMed

Insights

Oncolytic Newcastle disease virus (NDV) selectively targets tumor cells. Researchers found the small GTPase Rac1 is essential for NDV replication and oncolytic activity in tumorigenic cells.

Area of Science:

  • Oncolytic virology
  • Cancer biology
  • Molecular mechanisms of tumorigenesis

Background:

  • Oncolytic Newcastle disease virus (NDV) exhibits selective replication in tumor cells, but the underlying mechanisms remain unclear.
  • Tumorigenesis is associated with altered cellular processes that may influence susceptibility to oncolytic viruses.
  • Understanding these mechanisms is crucial for optimizing oncolytic virotherapy.

Purpose of the Study:

  • To investigate the molecular mechanisms linking tumorigenesis to selective oncolytic NDV sensitivity.
  • To identify specific cellular factors that confer susceptibility to NDV replication in transformed cells.
  • To explore the role of oncogenic pathways in modulating oncolytic virus efficacy.

Main Methods:

  • Utilized a multistage skin carcinogenesis model derived from HaCaT cells.
  • Assessed interferon signaling pathways in virus-sensitive and virus-resistant cells.
  • Employed oncogenic H-Ras for cell transformation and investigated its role in NDV replication.
  • Conducted siRNA screening to identify virus-sensitizing genes.
  • Validated the function of identified genes in NDV replication and cell growth.

Main Results:

  • No significant differences in interferon signaling were observed between tumor and non-tumorigenic cells.
  • Oncogenic H-Ras was necessary but not sufficient for NDV replication in transformed cells.
  • The small GTPase Rac1 was identified as essential for NDV replication and anchorage-independent growth in tumorigenic cells.
  • Rac1 expression alone was sufficient to confer NDV susceptibility and oncolytic cytotoxicity to non-tumorigenic cells.

Conclusions:

  • Rac1 is a key molecular link between tumorigenesis and oncolytic NDV sensitivity.
  • Rac1 plays a critical role in enabling selective viral replication and oncolytic effects in cancer cells.
  • Targeting Rac1 may enhance the efficacy of NDV-based oncolytic therapies.

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Ex Vivo Infection of Live Tissue with Oncolytic Viruses12:08

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: